🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this surveillance is to collect more safety and efficacy dat...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00704808
Treatments Being Tested
The primary protocol objective is to assess the impact of substituting puls...
Status
Active Not Recruiting
Location
Medical College of Wisconsin
Start Date
2021-06-03
Trial ID
NCT04747145
Treatments Being Tested
Purposes: The purpose of this phase-II clinical trial is to determine whet...
Status
Unknown
Location
China Medical University Hospital
Start Date
2005-05
Trial ID
NCT02772094
Treatments Being Tested
The overall objective of this study is to preliminarily evaluate the effica...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-09-30
Trial ID
NCT07715097
Treatments Being Tested
This clinical trial evaluates adding high-dose ascorbate (vitamin C) to sta...
Status
Active Not Recruiting
Location
Holden Comprehensive Cancer Center
Start Date
2017-03-13
Trial ID
NCT02344355
Treatments Being Tested
Cilengitide 2000 mg flat i.v. twice weekly is administered over a period of...
Status
Unknown
Location
Royal North Shore Hospital
Start Date
2009-11
Trial ID
NCT01124240
Treatments Being Tested
This is a phase II study of Bevacizumab plus Temodar and Tarceva in patient...
Status
Completed
Location
University of California San Francisco
Start Date
2007-09
Trial ID
NCT00525525
Treatments Being Tested
The proposed Phase IIB/III randomized, double-blind, placebo-controlled tri...
Status
Active Not Recruiting
Location
Institut Cancerologie de L'Ouest (ICO)
Start Date
2019-12-01
Trial ID
NCT04250922
This phase II trial studies how well whole brain radiation therapy works wi...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2018-12-04
Trial ID
NCT03746080
Treatments Being Tested
Surgical resection is curative for 75% of stage II and 50% of stage III col...
Status
Unknown
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2022-05-02
Trial ID
NCT05031975
Treatments Being Tested